Information  X 
Enter a valid email address

Silence Therapeutics PLC Ord5P (SLN)

Date Time Source Announcement
04 Mar 2021 7:29 am
RNS
Silence presents at Barclays Healthcare Conference
01 Mar 2021 7:00 am
RNS
Notice of Annual Results
26 Feb 2021 7:00 am
RNS
Silence & Mallinckrodt Initiate Work on 3rd Target
24 Feb 2021 3:09 pm
RNS
Holding(s) in Company
22 Feb 2021 7:00 am
RNS
Silence to Partake in March Investor Conferences
18 Feb 2021 7:00 am
RNS
Silence to present at SVB Leerink Conference
17 Feb 2021 7:00 am
RNS
First dosing for SLN360
15 Feb 2021 3:55 pm
RNS
Holding(s) in Company
  1:14 pm
RNS
Holding(s) in Company
12 Feb 2021 4:57 pm
RNS
Holding(s) in Company
  4:53 pm
RNS
Holding(s) in Company
  12:10 pm
RNS
Additional Listing and Total Voting Rights
11 Feb 2021 5:29 pm
RNS
Holding(s) in Company
  11:06 am
RNS
Holding(s) in Company
08 Feb 2021 4:28 pm
RNS
Additional listing and Total Voting Rights
05 Feb 2021 7:00 am
RNS
Silence Announces $45m Private Placement
29 Jan 2021 2:35 pm
RNS
Additional listing and Total Voting Rights
25 Jan 2021 12:41 pm
RNS
Additional listing and Total Voting Rights
07 Jan 2021 7:00 am
RNS
Holdings in Company
06 Jan 2021 11:08 am
RNS
Grant of Options
  10:08 am
RNS
Holding(s) in Company
  7:00 am
RNS
Board of Directors Appointment
  7:00 am
RNS
Silence Therapeutics Appoints Craig Tooman as CFO
05 Jan 2021 7:00 am
RNS
January Conference Schedule
04 Jan 2021 11:45 am
RNS
Holdings in Company
15 Dec 2020 12:28 pm
RNS
Holding(s) in Company
04 Dec 2020 5:08 pm
RNS
Additional listing and Total Voting Rights
03 Dec 2020 9:45 am
RNS
Director/PDMR Shareholding
  9:44 am
RNS
Director/PDMR Shareholding
17 Nov 2020 3:44 pm
RNS
Additional listing and Total Voting Rights
16 Nov 2020 7:00 am
RNS
Positive pre-clinical data presented
02 Nov 2020 7:00 am
RNS
Silence Therapeutics Appoints Dr. Marie Wikstr?m
29 Oct 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
16 Oct 2020 2:05 pm
RNS
Director/PDMR Shareholding
14 Oct 2020 1:15 pm
RNS
Additional listing and Total Voting Rights
12 Oct 2020 3:49 pm
RNS
Director/PDMR Shareholding
08 Oct 2020 7:00 am
RNS
Change to Executive Leadership Team
06 Oct 2020 4:25 pm
RNS
Additional Listing and Total Voting Rights
01 Oct 2020 7:00 am
RNS
Conference Participation
23 Sep 2020 8:59 am
RNS
Holding(s) in Company
  7:06 am
RNS
Second Price Monitoring Extn
  7:04 am
RNS
Price Monitoring Extension
22 Sep 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
14 Sep 2020 7:05 am
RNS
Grant of options
  7:00 am
RNS
Silence Therapeutics announces new CEO
  7:00 am
RNS
2020 interim results
08 Sep 2020 7:01 am
RNS
R&D update
  7:00 am
RNS
Instructions exchanging ordinary shares for ADSs
  7:00 am
RNS
Completion of Nasdaq listing
07 Sep 2020 5:47 pm
RNS
Holding(s) in Company
04 Sep 2020 2:18 pm
RNS
Holding(s) in Company
03 Sep 2020 7:00 am
RNS
Silence to Participate in US Investor Conferences
01 Sep 2020 7:00 am
RNS
Silence Therapeutics Notice of Results
21 Aug 2020 7:00 am
RNS
Silence Therapeutics Files Registration with SEC
23 Jul 2020 5:02 pm
RNS
Results of EGM
22 Jul 2020 4:29 pm
RNS
Holding(s) in Company
  4:24 pm
RNS
Holding(s) in Company
21 Jul 2020 7:00 am
RNS
Silence Therapeutics to Participate in Conferences
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t